Resmed Inc
SWB:RMEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
SWB:RMEA
|
US |
|
Piovan SpA
F:PV0
|
IT |
|
P
|
Pakuwon Jati Tbk PT
F:P04
|
ID |
|
GoGold Resources Inc
TSX:GGD
|
CA |
|
Weibo Corp
NASDAQ:WB
|
CN |
|
Cascades Inc
TSX:CAS
|
CA |
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
C
|
Cecep Costin New Materials Group Ltd
HKEX:2228
|
HK |
|
O
|
Old Dominion Freight Line Inc
SWB:ODF
|
US |
|
W
|
Werner Enterprises Inc
SWB:WE1
|
US |
|
I
|
Iluka Resources Ltd
OTC:ILKAF
|
AU |
|
PSP Swiss Property AG
F:P7S
|
CH |
|
Fresnillo PLC
LSE:FRES
|
MX |
|
M
|
Microsoft Corp
SWB:MSF
|
US |
|
L'Oreal SA
PAR:OR
|
FR |
|
N
|
Nextera Energy Inc
DUS:FP3
|
US |
|
C
|
C&C Group PLC
F:GCC
|
IE |
|
Cosmo Pharmaceuticals NV
F:C43
|
IE |
|
Acer Inc
TWSE:2353
|
TW |
Wall St Price Targets
RMEA Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RMEA is 23.23 EUR with a low forecast of 15.3 EUR and a high forecast of 30.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RMEA's stock price target?
Price Target
23.23
EUR
According to Wall Street analysts, the average 1-year price target for RMEA is 23.23 EUR with a low forecast of 15.3 EUR and a high forecast of 30.05 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 7%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 6 years is 12%.
